Library Subscription: Guest
Critical Reviews™ in Oncogenesis

Published 4 issues per year

ISSN Print: 0893-9675

ISSN Online: 2162-6448

SJR: 0.395 SNIP: 0.322 CiteScore™:: 2.5 H-Index: 54

Indexed in

Glioblastoma Heterogeneity and Cancer Cell Plasticity

Volume 19, Issue 5, 2014, pp. 327-336
DOI: 10.1615/CritRevOncog.2014011777
Get accessGet access

ABSTRACT

Glioblastoma (GBM) is the most common and malignant type of primary brain tumor. It represents one of the deadliest human cancers, with an average survival at diagnosis of about 1 year. This poor prognosis is due to therapeutic resistance and tumor recurrence after surgical removal. One of the most important hallmarks of GBM is tumor heterogeneity. Intertumor heterogeneity is mostly characterized by distinct genetic alterations that occur in individual tumors originating in the same organ and allows the classification of these tumors into different molecular subtypes. Intratumor heterogeneity−the diversity within individual tumors−has become the focus of research interest in the past few years, and tumor cell plasticity as a new source of cancer stem cells has added another level of complexity to this phenomenon. This review describes the molecular heterogeneity of GBMs at the transcriptome level and the expression profile-based classification of histopathologically indistinguishable tumors into different subtypes. In addition, the role of dedifferentiation of tumor cells into a stem cell-like state is discussed as a source of cellular heterogeneity within tumors, highlighting tumor cell plasticity as an important driver of GBM heterogeneity. Understanding tumor heterogeneity will help design better therapies against GBM and avoid tumor recurrence.

CITED BY
  1. Safa Ahmad R., Saadatzadeh Mohammad Reza, Cohen-Gadol Aaron A., Pollok Karen E., Bijangi-Vishehsaraei Khadijeh, Glioblastoma stem cells (GSCs) epigenetic plasticity and interconversion between differentiated non-GSCs and GSCs, Genes & Diseases, 2, 2, 2015. Crossref

  2. Lemée Jean-Michel, Clavreul Anne, Menei Philippe, Intratumoral heterogeneity in glioblastoma: don't forget the peritumoral brain zone, Neuro-Oncology, 17, 10, 2015. Crossref

  3. Correa Bruna R., de Araujo Patricia Rosa, Qiao Mei, Burns Suzanne C., Chen Chen, Schlegel Richard, Agarwal Seema, Galante Pedro A. F., Penalva Luiz O. F., Functional genomics analyses of RNA-binding proteins reveal the splicing regulator SNRPB as an oncogenic candidate in glioblastoma, Genome Biology, 17, 1, 2016. Crossref

  4. Derryberry Dakota Z., Cowperthwaite Matthew C., Wilke Claus O., Reproducibility of SNV-calling in multiple sequencing runs from single tumors, PeerJ, 4, 2016. Crossref

  5. Mir Tasika, Bernstein Mark, Are neurosurgeons prepared to electively resample glioblastoma in patients without symptomatic relapse? A qualitative study, British Journal of Neurosurgery, 30, 3, 2016. Crossref

  6. Bronisz Agnieszka, Godlewski Jakub, Chiocca E. Antonio, Extracellular Vesicles and MicroRNAs: Their Role in Tumorigenicity and Therapy for Brain Tumors, Cellular and Molecular Neurobiology, 36, 3, 2016. Crossref

  7. Stangherlin Lucas Matheus, Castro Fabiane Lucy Ferreira, Medeiros Raphael Salles Scortegagna, Guerra Juliana Mariotti, Kimura Lidia Midori, Shirata Neuza Kazumi, Nonogaki Suely, dos Santos Claudia Januário, Carlan Silva Maria Cristina, Nevels Michael, Human Cytomegalovirus DNA Quantification and Gene Expression in Gliomas of Different Grades, PLOS ONE, 11, 7, 2016. Crossref

  8. Wali Arvin R., Rennert Robert C., Wang Sonya G., Chen Clark C., Prophylactic anticonvulsants in patients with primary glioblastoma, Journal of Neuro-Oncology, 135, 2, 2017. Crossref

  9. BRYUKHOVETSKIY IGOR, BRYUKHOVETSKIY ANDREY, KHOTIMCHENKO YURI, MISCHENKO POLINA, Novel cellular and post-genomic technologies in the treatment of glioblastoma multiforme (Review), Oncology Reports, 35, 2, 2016. Crossref

  10. Bajetto Adriana, Pattarozzi Alessandra, Corsaro Alessandro, Barbieri Federica, Daga Antonio, Bosio Alessia, Gatti Monica, Pisaturo Valerio, Sirito Rodolfo, Florio Tullio, Different Effects of Human Umbilical Cord Mesenchymal Stem Cells on Glioblastoma Stem Cells by Direct Cell Interaction or Via Released Soluble Factors, Frontiers in Cellular Neuroscience, 11, 2017. Crossref

  11. Bielecka-Wajdman Anna M., Lesiak Marta, Ludyga Tomasz, Sieroń Aleksander, Obuchowicz Ewa, Reversing glioma malignancy: a new look at the role of antidepressant drugs as adjuvant therapy for glioblastoma multiforme, Cancer Chemotherapy and Pharmacology, 79, 6, 2017. Crossref

  12. Audia Alessandra, Conroy Siobhan, Glass Rainer, Bhat Krishna P. L., The Impact of the Tumor Microenvironment on the Properties of Glioma Stem-Like Cells, Frontiers in Oncology, 7, 2017. Crossref

  13. Chang En-Ling, Ting Chien-Yu, Hsu Po-Hong, Lin Yu-Chun, Liao En-Chi, Huang Chiung-Yin, Chang Yuan-Chih, Chan Hong-Lin, Chiang Chi-Shiun, Liu Hao-Li, Wei Kuo-Chen, Fan Ching-Hsiang, Yeh Chih-Kuang, Angiogenesis-targeting microbubbles combined with ultrasound-mediated gene therapy in brain tumors, Journal of Controlled Release, 255, 2017. Crossref

  14. Li Hao, Li Haowen, Hao Yajing, Jiao Yuming, Li Zhicen, Yue Haiyan, Xu Zhe, Wang Shuo, Cao Yong, Zhao Jizong, Differential long non-coding RNA and mRNA expression in differentiated human glioblastoma stem cells, Molecular Medicine Reports, 14, 3, 2016. Crossref

  15. Patrizii Michele, Bartucci Monica, Pine Sharon R., Sabaawy Hatem E., Utility of Glioblastoma Patient-Derived Orthotopic Xenografts in Drug Discovery and Personalized Therapy, Frontiers in Oncology, 8, 2018. Crossref

  16. Stepp Herbert, Stummer Walter, 5‐ALA in the management of malignant glioma, Lasers in Surgery and Medicine, 50, 5, 2018. Crossref

  17. Piper Rory J., Senthil Keerthi K., Yan Jiun-Lin, Price Stephen J., Neuroimaging classification of progression patterns in glioblastoma: a systematic review, Journal of Neuro-Oncology, 139, 1, 2018. Crossref

  18. Jovčevska Ivana, Sequencing the next generation of glioblastomas, Critical Reviews in Clinical Laboratory Sciences, 55, 4, 2018. Crossref

  19. Ditmer Austin, Zhang Bin, Shujaat Taimur, Pavlina Andrew, Luibrand Nicholas, Gaskill-Shipley Mary, Vagal Achala, Diagnostic accuracy of MRI texture analysis for grading gliomas, Journal of Neuro-Oncology, 140, 3, 2018. Crossref

  20. Matias Diana, Dubois Luiz Gustavo, Pontes Bruno, Rosário Luciane, Ferrer Valeria Pereira, Balça-Silva Joana, Fonseca Anna Carolina Carvalho, Macharia Lucy Wanjiku, Romão Luciana, e Spohr Tania Cristina Leite de Sampaio, Chimelli Leila, Filho Paulo Niemeyer, Lopes Maria Celeste, Abreu José Garcia, Lima Flavia Regina Souza, Moura-Neto Vivaldo, GBM-Derived Wnt3a Induces M2-Like Phenotype in Microglial Cells Through Wnt/β-Catenin Signaling, Molecular Neurobiology, 56, 2, 2019. Crossref

  21. Chatziathanasiadou Maria V., Stylos Evgenios K., Giannopoulou Efstathia, Spyridaki Maria-Helen, Briasoulis Evangelos, Kalofonos Haralabos P., Crook Tim, Syed Nelofer, Sivolapenko Gregory B., Tzakos Andreas G., Development of a validated LC-MS/MS method for the in vitro and in vivo quantitation of sunitinib in glioblastoma cells and cancer patients, Journal of Pharmaceutical and Biomedical Analysis, 164, 2019. Crossref

  22. Barbieri Federica, Würth Roberto, Pattarozzi Alessandra, Verduci Ivan, Mazzola Chiara, Cattaneo Maria G., Tonelli Michele, Solari Agnese, Bajetto Adriana, Daga Antonio, Vicentini Lucia M., Mazzanti Michele, Florio Tullio, Inhibition of Chloride Intracellular Channel 1 (CLIC1) as Biguanide Class-Effect to Impair Human Glioblastoma Stem Cell Viability, Frontiers in Pharmacology, 9, 2018. Crossref

  23. Krol Ilona, Castro-Giner Francesc, Maurer Martina, Gkountela Sofia, Szczerba Barbara Maria, Scherrer Ramona, Coleman Niamh, Carreira Suzanne, Bachmann Felix, Anderson Stephanie, Engelhardt Marc, Lane Heidi, Evans Thomas Ronald Jeffry, Plummer Ruth, Kristeleit Rebecca, Lopez Juanita, Aceto Nicola, Detection of circulating tumour cell clusters in human glioblastoma, British Journal of Cancer, 119, 4, 2018. Crossref

  24. Jhaveri Aditi, Deshpande Pranali, Pattni Bhushan, Torchilin Vladimir, Transferrin-targeted, resveratrol-loaded liposomes for the treatment of glioblastoma, Journal of Controlled Release, 277, 2018. Crossref

  25. Geraldo Luiz Henrique Medeiros, Garcia Celina, da Fonseca Anna Carolina Carvalho, Dubois Luiz Gustavo Feijó, de Sampaio e Spohr Tânia Cristina Leite, Matias Diana, de Camargo Magalhães Eduardo Sabino, do Amaral Rackele Ferreira, da Rosa Barbara Gomes, Grimaldi Izabella, Leser Felipe Sceanu, Janeiro José Marcos, Macharia Lucy, Wanjiru Caroline, Pereira Claudia Maria, Moura-Neto Vivaldo, Freitas Catarina, Lima Flavia Regina Souza, Glioblastoma Therapy in the Age of Molecular Medicine, Trends in Cancer, 5, 1, 2019. Crossref

  26. Alinezhadbalalami Nastaran, Douglas Temple A., Balani Nikita, Verbridge Scott S., Davalos Rafael V., The feasibility of using dielectrophoresis for isolation of glioblastoma subpopulations with increased stemness, ELECTROPHORESIS, 2019. Crossref

  27. Wang Yulin, Zhao Weijiang, Liu Xin, Guan Gefei, Zhuang Minghua, ARL3 is downregulated and acts as a prognostic biomarker in glioma, Journal of Translational Medicine, 17, 1, 2019. Crossref

  28. Shin Juhyun, Choi Jun-Ha, Jung Seunghwa, Jeong Somi, Oh Jeongheon, Yoon Do-Young, Rhee Man Hee, Ahn Jaehong, Kim Se-Hyuk, Oh Jae-Wook, MUDENG Expression Profiling in Cohorts and Brain Tumor Biospecimens to Evaluate Its Role in Cancer, Frontiers in Genetics, 10, 2019. Crossref

  29. Valdebenito Silvana, D'Amico Daniela, Eugenin Eliseo, Novel approaches for glioblastoma treatment: Focus on tumor heterogeneity, treatment resistance, and computational tools, CANCER REPORTS, 2, 6, 2019. Crossref

  30. Godlewski Jakub, Lenart Jacek, Salinska Elzbieta, MicroRNA in Brain pathology: Neurodegeneration the Other Side of the Brain Cancer, Non-Coding RNA, 5, 1, 2019. Crossref

  31. Honorato Jessica R., Hauser‐Davis Rachel A., Saggioro Enrico M., Correia Fábio V., Sales‐Junior Sidney F., Soares Lorena O. S., Lima Leandro da R., Moura‐Neto Vivaldo, Lopes Giselle P. de F., Spohr Tania C. L. de S., Role of Sonic hedgehog signaling in cell cycle, oxidative stress, and autophagy of temozolomide resistant glioblastoma, Journal of Cellular Physiology, 235, 4, 2020. Crossref

  32. Berens Michael E., Sood Anup, Barnholtz-Sloan Jill S., Graf John F., Cho Sanghee, Kim Seungchan, Kiefer Jeffrey, Byron Sara A., Halperin Rebecca F., Nasser Sara, Adkins Jonathan, Cuyugan Lori, Devine Karen, Ostrom Quinn, Couce Marta, Wolansky Leo, McDonough Elizabeth, Schyberg Shannon, Dinn Sean, Sloan Andrew E., Prados Michael, Phillips Joanna J., Nelson Sarah J., Liang Winnie S., Al-Kofahi Yousef, Rusu Mirabela, Zavodszky Maria I., Ginty Fiona, Najbauer Joseph, Multiscale, multimodal analysis of tumor heterogeneity in IDH1 mutant vs wild-type diffuse gliomas, PLOS ONE, 14, 12, 2019. Crossref

  33. Lyakhova Irina, Piatkova Mariia, Khotimchenko Yuri, Zhidkov Maxim, Kantemirov Alexey, Khotimchenko Rodion, Bryukhovetskiy Andrey, Sharma Aruna, Sharma Hari Shanker, Bryukhovetskiy Igor, 3-Bromofascaplysin is a prospective chemical compound for developing new chemotherapy agents in glioblastoma treatment, in Novel Therapeutic Advances in Glioblastoma, 151, 2020. Crossref

  34. Du Juan, Xu Yanning, Sasada Saki, Oo Aung Ko Ko, Hassan Ghmkin, Mahmud Hafizah, Khayrani Apriliana Cahya, Alam Md Jahangir, Kumon Kazuki, Uesaki Ryo, Afify Said M., Mansour Hager M., Nair Neha, Zahra Maram H., Seno Akimasa, Okada Nobuhiro, Chen Ling, Yan Ting, Seno Masaharu, Signaling Inhibitors Accelerate the Conversion of mouse iPS Cells into Cancer Stem Cells in the Tumor Microenvironment, Scientific Reports, 10, 1, 2020. Crossref

  35. Falco Matías M, Peña-Chilet María, Loucera Carlos, Hidalgo Marta R, Dopazo Joaquín, Mechanistic models of signaling pathways deconvolute the glioblastoma single-cell functional landscape, NAR Cancer, 2, 2, 2020. Crossref

  36. Bhargava Shruti, Visvanathan Abhirami, Patil Vikas, Kumar Anuj, Kesari Santosh, Das Saumitra, Hegde Alangar S., Arivazhagan Arimappamagan, Santosh Vani, Somasundaram Kumaravel, IGF2 mRNA binding protein 3 (IMP3) promotes glioma cell migration by enhancing the translation of RELA/p65, Oncotarget, 8, 25, 2017. Crossref

  37. Zhang Yizhuang, Zhou Na, Yu Xiuyan, Zhang Xuehui, Li Shanxin, Lei Zhen, Hu Ruobi, Li Hui, Mao Yiqing, Wang Xi, Zhang Jinshu, Li Yuan, Guo Hongyan, Irwin David M., Niu Gang, Tan Huanran, Tumacrophage: macrophages transformed into tumor stem-like cells by virulent genetic material from tumor cells, Oncotarget, 8, 47, 2017. Crossref

  38. Kuang Xiao-yan, Jiang Xue-feng, Chen Cong, Su Xiao-rui, Shi Yu, Wu Jin-rong, Zhang Peng, Zhang Xin-li, Cui You-hong, Ping Yi-fang, Bian Xiu-wu, Expressions of glia maturation factor-β by tumor cells and endothelia correlate with neovascularization and poor prognosis in human glioma, Oncotarget, 7, 52, 2016. Crossref

  39. Jang Kevin, Russo Carlo, Di Ieva Antonio, Radiomics in gliomas: clinical implications of computational modeling and fractal-based analysis, Neuroradiology, 62, 7, 2020. Crossref

  40. Papale Marco, Buccarelli Mariachiara, Mollinari Cristiana, Russo Matteo A., Pallini Roberto, Ricci-Vitiani Lucia, Tafani Marco, Hypoxia, Inflammation and Necrosis as Determinants of Glioblastoma Cancer Stem Cells Progression, International Journal of Molecular Sciences, 21, 8, 2020. Crossref

  41. Dussaussois-Montagne Audrey, Jaillet Jérôme, Babin Laetitia, Verrelle Pierre, Karayan-Tapon Lucie, Renault Sylvaine, Rousselot-Denis Cécilia, Zemmoura Ilyess, Augé-Gouillou Corinne, SETMAR isoforms in glioblastoma: A matter of protein stability, Oncotarget, 8, 6, 2017. Crossref

  42. Qiu Xia, Jiao Jianguo, Li Yidong, Tian Tian, Overexpression of FZD7 promotes glioma cell proliferation by upregulating TAZ, Oncotarget, 7, 52, 2016. Crossref

  43. Šamec Neja, Zottel Alja, Videtič Paska Alja, Jovčevska Ivana, Nanomedicine and Immunotherapy: A Step Further towards Precision Medicine for Glioblastoma, Molecules, 25, 3, 2020. Crossref

  44. Garrett Anne-Marie, Lastakchi Sarah, McConville Christopher, The Personalisation of Glioblastoma Treatment Using Whole Exome Sequencing: A Pilot Study, Genes, 11, 2, 2020. Crossref

  45. Londhe Vaishali Y., Date Varada, Personalized neoantigen vaccines: a glimmer of hope for glioblastoma, Expert Review of Vaccines, 19, 5, 2020. Crossref

  46. Wang Hexiang, Liu Zhenyou, Zhang Yong, Hou Feng, Fu Weiwei, Lin Jizheng, Liu Yingchao, Liu Xuejun, Additional Diagnostic Value of Unenhanced Computed Tomography plus Diffusion-Weighted Imaging Combined with Routine Magnetic Resonance Imaging Findings of Early-Stage Gliblastoma, BioMed Research International, 2020, 2020. Crossref

  47. Xiong Anqi, Spyrou Argyris, Forsberg-Nilsson Karin, Involvement of Heparan Sulfate and Heparanase in Neural Development and Pathogenesis of Brain Tumors, in Heparanase, 1221, 2020. Crossref

  48. Shevchenko Valeriy, Arnotskaya Natalia, Zaitsev Sergei, Sharma Aruna, Sharma Hari Shanker, Bryukhovetskiy Andrey, Pak Oleg, Khotimchenko Yuri, Bryukhovetskiy Igor, Proteins of Wnt signaling pathway in cancer stem cells of human glioblastoma, in Novel Therapeutic Advances in Glioblastoma, 151, 2020. Crossref

  49. Guadagno Elia, Vitiello Michela, Francesca Paola, Calì Gaetano, Caponnetto Federica, Cesselli Daniela, Camorani Simona, Borrelli Giorgio, Califano Marialuisa, Cappabianca Paolo, Arra Claudio, Crescenzi Elvira, Cerchia Laura, De Caro Maria Laura Del Basso, Fedele Monica, PATZ1 is a new prognostic marker of glioblastoma associated with the stem-like phenotype and enriched in the proneural subtype, Oncotarget, 8, 35, 2017. Crossref

  50. Mozhei Oleg, G. Teschemacher Anja, Kasparov Sergey, Viral Vectors as Gene Therapy Agents for Treatment of Glioblastoma, Cancers, 12, 12, 2020. Crossref

  51. Brancato Valentina, Nuzzo Silvia, Tramontano Liberatore, Condorelli Gerolama, Salvatore Marco, Cavaliere Carlo, Predicting Survival in Glioblastoma Patients Using Diffusion MR Imaging Metrics—A Systematic Review, Cancers, 12, 10, 2020. Crossref

  52. Ayensa-Jiménez Jacobo, Pérez-Aliacar Marina, Randelovic Teodora, Oliván Sara, Fernández Luis, Sanz-Herrera José Antonio, Ochoa Ignacio, Doweidar Mohamed H., Doblaré Manuel, Mathematical formulation and parametric analysis of in vitro cell models in microfluidic devices: application to different stages of glioblastoma evolution, Scientific Reports, 10, 1, 2020. Crossref

  53. De La Rosa Javier , Urdiciain Alejandro , Zazpe Idoya , Zelaya Mar�a , Mel�ndez B�rbara , Rey Juan , Idoate Miguel , Castresana Javier , The synergistic effect of DZ‑NEP, panobinostat and temozolomide reduces clonogenicity and induces apoptosis in glioblastoma cells, International Journal of Oncology, 2019. Crossref

  54. Cuenca Marina B., Canedo Lucía, Perez-Castro Carolina, Grecco Hernan E., An Integrative and Modular Framework to Recapitulate Emergent Behavior in Cell Migration, Frontiers in Cell and Developmental Biology, 8, 2020. Crossref

  55. Kuang Xiao-Yan, Ren Yong, Chen Cong, Su Jun, Li Hua-Mei, Liu Si-Jia, Sun Tian-Jing, Mu Dong-Yun, lu Jing, Chen Lan, Qu Hang-Da, Cui You-Hong, Yu An-Yong, Yao Xiao-Hong, Quantitative analysis for the differences in vasculogenic activity and sensitivity to angiogenic stimulants between human glioma cells and normal endothelial cells, Brain Research, 1748, 2020. Crossref

  56. Ryskalin Larisa, Biagioni Francesca, Lenzi Paola, Frati Alessandro, Fornai Francesco, mTOR Modulates Intercellular Signals for Enlargement and Infiltration in Glioblastoma Multiforme, Cancers, 12, 9, 2020. Crossref

  57. Pinho Marco C., Bera Kaustav, Beig Niha, Tiwari Pallavi, MRI Morphometry in Brain Tumors: Challenges and Opportunities in Expert, Radiomic, and Deep-Learning-Based Analyses, in Brain Tumors, 158, 2021. Crossref

  58. Pontius W. Dean, Wallace Lisa C., Fife Katrina, Hubert Christopher G., Human Glioblastoma Organoids to Model Brain Tumor Heterogeneity Ex Vivo, in Brain Tumors, 158, 2021. Crossref

  59. Desland Fiona A., Hormigo Adília, The CNS and the Brain Tumor Microenvironment: Implications for Glioblastoma Immunotherapy, International Journal of Molecular Sciences, 21, 19, 2020. Crossref

  60. Ali Md Yousuf, Oliva Claudia R., Noman Abu Shadat M., Allen Bryan G., Goswami Prabhat C., Zakharia Yousef, Monga Varun, Spitz Douglas R., Buatti John M., Griguer Corinne E., Radioresistance in Glioblastoma and the Development of Radiosensitizers, Cancers, 12, 9, 2020. Crossref

  61. Dekker Lennard J M, Kannegieter Nynke M, Haerkens Femke, Toth Emma, Kros Johan M, Steenhoff Hov Dag Are, Fillebeen Julien, Verschuren Lars, Leenstra Sieger, Ressa Anna, Luider Theo M, Multiomics profiling of paired primary and recurrent glioblastoma patient tissues, Neuro-Oncology Advances, 2, 1, 2020. Crossref

  62. Li Bing , Zhou Chun , Yi Liang , Xu Lunshan , Xu Minhui , Effect and molecular mechanism of mTOR inhibitor rapamycin on temozolomide‑induced autophagic death of U251 glioma cells, Oncology Letters, 2017. Crossref

  63. Nguyen Hong-My, Guz-Montgomery Kirsten, Lowe Devin B., Saha Dipongkor, Pathogenetic Features and Current Management of Glioblastoma, Cancers, 13, 4, 2021. Crossref

  64. Zhang Jingwen, Fu Minjie, Zhang Mengli, Zhang Jinsen, Du Zunguo, Zhang Hongyi, Hua Wei, Mao Ying, DDX60 Is Associated With Glioma Malignancy and Serves as a Potential Immunotherapy Biomarker, Frontiers in Oncology, 11, 2021. Crossref

  65. Abbaszade Zaka, Bagca Bakiye Goker, Avci Cigir Biray, Molecular biological investigation of temozolomide and KC7F2 combination in U87MG glioma cell line, Gene, 776, 2021. Crossref

  66. Hermawan Adam, Putri Herwandhani, Systematic analysis of potential targets of the curcumin analog pentagamavunon-1 (PGV-1) in overcoming resistance of glioblastoma cells to bevacizumab, Saudi Pharmaceutical Journal, 29, 11, 2021. Crossref

  67. Storari Lorenzo, Signorini Manuel, Barbari Valerio, Mourad Firas, Bisconti Mattia, Salomon Mattia, Rossettini Giacomo, Maselli Filippo, A Thoracic Outlet Syndrome That Concealed a Glioblastoma. Findings from a Case Report, Medicina, 57, 9, 2021. Crossref

  68. Dapash Mark, Castro Brandyn, Hou David, Lee-Chang Catalina, Current Immunotherapeutic Strategies for the Treatment of Glioblastoma, Cancers, 13, 18, 2021. Crossref

  69. Schmitt Beate M., Boewe Anne S., Götz Claudia, Philipp Stephan E., Urbschat Steffi, Oertel Joachim, Menger Michael D., Laschke Matthias W., Ampofo Emmanuel, CK2 Activity Mediates the Aggressive Molecular Signature of Glioblastoma Multiforme by Inducing Nerve/Glial Antigen (NG)2 Expression, Cancers, 13, 7, 2021. Crossref

  70. Stevanovic Milena, Kovacevic-Grujicic Natasa, Mojsin Marija, Milivojevic Milena, Drakulic Danijela, SOX transcription factors and glioma stem cells: Choosing between stemness and differentiation, World Journal of Stem Cells, 13, 10, 2021. Crossref

  71. Nguyen H. D., Allaire A., Diamandis P., Bisaillon M., Scott M. S., Richer M., A machine learning analysis of a “normal-like” IDH-WT diffuse glioma transcriptomic subgroup associated with prolonged survival reveals novel immune and neurotransmitter-related actionable targets, BMC Medicine, 18, 1, 2020. Crossref

  72. Stella Michele, Falzone Luca, Caponnetto Angela, Gattuso Giuseppe, Barbagallo Cristina, Battaglia Rosalia, Mirabella Federica, Broggi Giuseppe, Altieri Roberto, Certo Francesco, Caltabiano Rosario, Barbagallo Giuseppe Maria Vincenzo, Musumeci Paolo, Ragusa Marco, Pietro Cinzia Di, Libra Massimo, Purrello Michele, Barbagallo Davide, Serum Extracellular Vesicle-Derived circHIPK3 and circSMARCA5 Are Two Novel Diagnostic Biomarkers for Glioblastoma Multiforme, Pharmaceuticals, 14, 7, 2021. Crossref

  73. Simionescu Natalia, Zonda Radu, Petrovici Anca Roxana, Georgescu Adriana, The Multifaceted Role of Extracellular Vesicles in Glioblastoma: microRNA Nanocarriers for Disease Progression and Gene Therapy, Pharmaceutics, 13, 7, 2021. Crossref

  74. Greco Francesco, Anastasi Federica, Pardini Luca Fidia, Dilillo Marialaura, Vannini Eleonora, Baroncelli Laura, Caleo Matteo, McDonnell Liam A., Longitudinal Bottom-Up Proteomics of Serum, Serum Extracellular Vesicles, and Cerebrospinal Fluid Reveals Candidate Biomarkers for Early Detection of Glioblastoma in a Murine Model, Molecules, 26, 19, 2021. Crossref

  75. Rousso-Noori Liat, Mastandrea Ignacio, Talmor Shauli, Waks Tova, Globerson Levin Anat, Haugas Maarja, Teesalu Tambet, Alvarez-Vallina Luis, Eshhar Zelig, Friedmann-Morvinski Dinorah, P32-specific CAR T cells with dual antitumor and antiangiogenic therapeutic potential in gliomas, Nature Communications, 12, 1, 2021. Crossref

  76. Xavier Mary-Ann, Rezende Fernando, Titze-de-Almeida Ricardo, Cornelissen Bart, BRCAness as a Biomarker of Susceptibility to PARP Inhibitors in Glioblastoma Multiforme, Biomolecules, 11, 8, 2021. Crossref

  77. Gazaille Claire, Sicot Marion, Saulnier Patrick, Eyer Joël, Bastiat Guillaume, Local Delivery and Glioblastoma: Why Not Combining Sustained Release and Targeting?, Frontiers in Medical Technology, 3, 2021. Crossref

  78. Benecke Laura, Coray Mali, Umbricht Sandra, Chiang Dapi, Figueiró Fabrício, Muller Laurent, Exosomes: Small EVs with Large Immunomodulatory Effect in Glioblastoma, International Journal of Molecular Sciences, 22, 7, 2021. Crossref

  79. Angel Inbar, Pilo Kerman Ori, Rousso-Noori Liat, Friedmann-Morvinski Dinorah, Tenascin C promotes cancer cell plasticity in mesenchymal glioblastoma, Oncogene, 39, 46, 2020. Crossref

  80. Fathi Kazerooni Anahita, Bagley Stephen J., Akbari Hamed, Saxena Sanjay, Bagheri Sina, Guo Jun, Chawla Sanjeev, Nabavizadeh Ali, Mohan Suyash, Bakas Spyridon, Davatzikos Christos, Nasrallah MacLean P., Applications of Radiomics and Radiogenomics in High-Grade Gliomas in the Era of Precision Medicine, Cancers, 13, 23, 2021. Crossref

  81. Bae Kideog, Xin Le, Zheng Wei, Tang Carol, Ang Beng-Ti, Huang Zhiwei, Mapping the Intratumoral Heterogeneity in Glioblastomas with Hyperspectral Stimulated Raman Scattering Microscopy, Analytical Chemistry, 93, 4, 2021. Crossref

  82. D’Amico Agata Grazia, Maugeri Grazia, Vanella Luca, Pittalà Valeria, Reglodi Dora, D’Agata Velia, Multimodal Role of PACAP in Glioblastoma, Brain Sciences, 11, 8, 2021. Crossref

  83. Nousi Aimilia, Søgaard Maria Tangen, Audoin Mélanie, Jauffred Liselotte, Single-cell tracking reveals super-spreading brain cancer cells with high persistence, Biochemistry and Biophysics Reports, 28, 2021. Crossref

  84. Maravat Marion, Bertrand Marylène, Landon Céline, Fayon Franck, Morisset-Lopez Séverine, Sarou-Kanian Vincent, Decoville Martine, Complementary Nuclear Magnetic Resonance-Based Metabolomics Approaches for Glioma Biomarker Identification in a Drosophila melanogaster Model, Journal of Proteome Research, 20, 8, 2021. Crossref

  85. Burster Timo, Gärtner Fabian, Bulach Christiane, Zhanapiya Anuar, Gihring Adrian, Knippschild Uwe, Regulation of MHC I Molecules in Glioblastoma Cells and the Sensitizing of NK Cells, Pharmaceuticals, 14, 3, 2021. Crossref

  86. Li Hui, Zhong Rui, He Chunying, Tang Chenchen, Cui Heran, Li Rixin, Liu Yan, Lan Shaowei, Cheng Ying, Colony‑stimulating factor CSF2 mediates the phenotypic plasticity of small‑cell lung cancer by regulating the p‑STAT3/MYC pathway, Oncology Reports, 48, 1, 2022. Crossref

  87. Zhou Hongzhang, Xu Rong, Mei Haitao, Zhang Ling, Yu Qiyun, Liu Rong, Fan Bing, COSTA André Luiz Ferreira, Application of Enhanced T1WI of MRI Radiomics in Glioma Grading, International Journal of Clinical Practice, 2022, 2022. Crossref

  88. Lié Oriane, Virolle Thierry, Gabut Mathieu, Pasquier Claude, Zemmoura Ilyess, Augé-Gouillou Corinne, SETMAR Shorter Isoform: A New Prognostic Factor in Glioblastoma, Frontiers in Oncology, 11, 2022. Crossref

  89. Atluri Rohini, Korir Daniel, Choi Tae-Youl, Simmons Denise Perry, Empirical Studies on Effect of Low-Level Laser Treatment on Glioblastoma Multiforme in Combination with Ag-PMMA-PAA Nanoparticles: Paired Red Region Optical-Property Treatment Platform, Applied Nano, 3, 2, 2022. Crossref

  90. Chen Jia-Qi, Zhang Nuo, Su Zhi-Lin, Qiu Hui-Guo, Zhuang Xin-Guo, Tao Zhi-hua, Integrated Analysis to Obtain Potential Prognostic Signature in Glioblastoma, Frontiers in Integrative Neuroscience, 15, 2022. Crossref

  91. Wang Jiao, Toregrosa-Allen Sandra, Elzey Bennett D., Utturkar Sagar, Lanman Nadia Atallah, Bernal-Crespo Victor, Behymer Matthew M., Knipp Gregory T., Yun Yeonhee, Veronesi Michael C., Sinn Anthony L., Pollok Karen E., Brutkiewicz Randy R., Nevel Kathryn S., Matosevic Sandro, Multispecific targeting of glioblastoma with tumor microenvironment-responsive multifunctional engineered NK cells, Proceedings of the National Academy of Sciences, 118, 45, 2021. Crossref

  92. Shen Yaoqing, Grisdale Cameron J., Islam Sumaiya A., Bose Pinaki, Lever Jake, Zhao Eric Y., Grinshtein Natalie, Ma Yussanne, Mungall Andrew J., Moore Richard A., Lun Xueqing, Senger Donna L., Robbins Stephen M., Wang Alice Yijun, MacIsaac Julia L., Kobor Michael S., Luchman H. Artee, Weiss Samuel, Chan Jennifer A., Blough Michael D., Kaplan David R., Cairncross J. Gregory, Marra Marco A., Jones Steven J. M., Comprehensive genomic profiling of glioblastoma tumors, BTICs, and xenografts reveals stability and adaptation to growth environments, Proceedings of the National Academy of Sciences, 116, 38, 2019. Crossref

  93. Lastakchi Sarah, Olaloko Mary Kanyinsola, McConville Christopher, A Potential New Treatment for High-Grade Glioma: A Study Assessing Repurposed Drug Combinations against Patient-Derived High-Grade Glioma Cells, Cancers, 14, 11, 2022. Crossref

  94. Ayensa-Jiménez Jacobo, Doweidar Mohamed H., Sanz-Herrera Jose A., Doblare Manuel, Lavrik Inna, Understanding glioblastoma invasion using physically-guided neural networks with internal variables, PLOS Computational Biology, 18, 4, 2022. Crossref

  95. Rom M., Schott R., Pencreac’h E., Cébula H., Cox D., Bender L., Antoni D., Lhermitte B., Noel G., Analyse de l’impact des résultats du séquençage de nouvelle génération chez les patients atteints de glioblastome, Cancer/Radiothérapie, 2022. Crossref

  96. Griffin Cassandra P, Paul Christine L, Alexander Kimberley L, Walker Marjorie M, Hondermarck Hubert, Lynam James, Postmortem brain donations vs premortem surgical resections for glioblastoma research: viewing the matter as a whole, Neuro-Oncology Advances, 4, 1, 2022. Crossref

  97. Daubon Thomas, Magaut Rarahu, Bikfalvi Andreas, Tumor Cell Invasion and the Tumor Microenvironment: Special Focus on Brain Tumors, in Tumor Microenvironment, 1329, 2021. Crossref

  98. Nandhu Mohan S., Behera Prajna, Bhaskaran Vivek, Longo Sharon L., Barrera-Arenas Lina M., Sengupta Sadhak, Rodriguez-Gil Diego J., Chiocca E. Antonio, Viapiano Mariano S., Development of a Function-Blocking Antibody Against Fibulin-3 as a Targeted Reagent for Glioblastoma, Clinical Cancer Research, 24, 4, 2018. Crossref

  99. Mathew Elza N., Berry Bethany C., Yang Hong Wei, Carroll Rona S., Johnson Mark D., Delivering Therapeutics to Glioblastoma: Overcoming Biological Constraints, International Journal of Molecular Sciences, 23, 3, 2022. Crossref

  100. Pérez-Aliacar Marina, Doweidar Mohamed H., Doblaré Manuel, Ayensa-Jiménez Jacobo, Predicting cell behaviour parameters from glioblastoma on a chip images. A deep learning approach, Computers in Biology and Medicine, 135, 2021. Crossref

  101. Bausart Mathilde, Préat Véronique, Malfanti Alessio, Immunotherapy for glioblastoma: the promise of combination strategies, Journal of Experimental & Clinical Cancer Research, 41, 1, 2022. Crossref

  102. Ma Huihui, Zhao Chenggang, Zhao Zhiyang, Hu Lizhu, Ye Fang, Wang Hongzhi, Fang Zhiyou, Wu Yuejin, Chen Xueran, Specific glioblastoma multiforme prognostic-subtype distinctions based on DNA methylation patterns, Cancer Gene Therapy, 27, 9, 2020. Crossref

  103. Gravina Giovanni Luca, Colapietro Alessandro, Mancini Andrea, Rossetti Alessandra, Martellucci Stefano, Ventura Luca, Di Franco Martina, Marampon Francesco, Mattei Vincenzo, Biordi Leda Assunta, Otterlei Marit, Festuccia Claudio, ATX-101, a Peptide Targeting PCNA, Has Antitumor Efficacy Alone or in Combination with Radiotherapy in Murine Models of Human Glioblastoma, Cancers, 14, 2, 2022. Crossref

  104. Sanati Mehdi, Aminyavari Samaneh, Mollazadeh Hamid, Bibak Bahram, Mohtashami Elmira, Afshari Amir R., How do phosphodiesterase-5 inhibitors affect cancer? A focus on glioblastoma multiforme, Pharmacological Reports, 74, 2, 2022. Crossref

  105. Singh Simranjit X., Yang Rui, Roso Kristen, Hansen Landon J., Du Changzheng, Chen Lee H., Greer Paula K., Pirozzi Christopher J., He Yiping, Purine Synthesis Inhibitor L-Alanosine Impairs Mitochondrial Function and Stemness of Brain Tumor Initiating Cells, Biomedicines, 10, 4, 2022. Crossref

  106. Bi Ying, Wu Zeng-Hong, Cao Fei, Prognostic value and immune relevancy of a combined autophagy-, apoptosis- and necrosis-related gene signature in glioblastoma, BMC Cancer, 22, 1, 2022. Crossref

  107. do Nascimento Ravena Pereira, dos Santos Balbino Lino, Amparo Jéssika Alves Oliveira, Soares Janaina Ribeiro Pereira, da Silva Karina Costa, Santana Monique Reis, Almeida Áurea Maria Alves Nunes, da Silva Victor Diógenes Amaral, Costa Maria de Fátima Dias, Ulrich Henning, Moura-Neto Vivaldo, Lopes Giselle Pinto de Faria, Costa Silvia Lima, Neuroimmunomodulatory Properties of Flavonoids and Derivates: A Potential Action as Adjuvants for the Treatment of Glioblastoma, Pharmaceutics, 14, 1, 2022. Crossref

  108. Ghosh Souvik, Kumar Viney, Mukherjee Haimanti, Lahiri Debrupa, Roy Partha, Nutraceutical regulation of miRNAs involved in neurodegenerative diseases and brain cancers, Heliyon, 7, 6, 2021. Crossref

  109. Yan Tengfeng, Tian Daofeng, Chen Junhui, Tan Yinqiu, Cheng Yue, Ye Liguo, Deng Gang, Liu Baohui, Yuan Fanen, Zhang Shenqi, Cai Linzhi, Chen Qianxue, FCGBP Is a Prognostic Biomarker and Associated With Immune Infiltration in Glioma, Frontiers in Oncology, 11, 2022. Crossref

  110. Bobholz S.A., Lowman A.K., Brehler M., Kyereme F., Duenweg S.R., Sherman J., McGarry S.D., Cochran E.J., Connelly J., Mueller W.M., Agarwal M., Banerjee A., LaViolette P.S., Radio-Pathomic Maps of Cell Density Identify Brain Tumor Invasion beyond Traditional MRI-Defined Margins, American Journal of Neuroradiology, 43, 5, 2022. Crossref

  111. Anjum Komal, Shagufta Bibi Ibtesam, Abbas Syed Qamar, Patel Seema, Khan Ishrat, Shah Sayed Asmat Ali, Akhter Najeeb, Hassan Syed Shams ul, Current status and future therapeutic perspectives of glioblastoma multiforme (GBM) therapy: A review, Biomedicine & Pharmacotherapy, 92, 2017. Crossref

  112. Balasubbramanian Dakshnapriya, Gao Yao, Bielenberg Diane R., Neuropilins as Cancer Biomarkers: A Focus on Neuronal Origin and Specific Cell Functions, in Biomarkers of the Tumor Microenvironment, 2022. Crossref

  113. Currie S., Fatania K., Matthew R., Wurdak H., Chakrabarty A., Murray L., Short S., A Comprehensive Clinical Review of Adult-Type Diffuse Glioma Incorporating the 2021 World Health Organization Classification, Neurographics, 12, 2, 2022. Crossref

  114. Kefayat Amirhosein, Amouheidari Alireza, Ghahremani Fatemeh, Alirezaei Zahra, Diagnostic and prognostic value of stem cell factor plasma level in glioblastoma multiforme patients, Cancer Medicine, 10, 15, 2021. Crossref

  115. Kundu Somanath, Nandhu Mohan S, Longo Sharon L, Longo John A, Rai Shawn, Chin Lawrence S, Richardson Timothy E, Viapiano Mariano S, The scaffolding protein DLG5 promotes glioblastoma growth by controlling Sonic Hedgehog signaling in tumor stem cells, Neuro-Oncology, 24, 8, 2022. Crossref

  116. Ghosh Krishnendu, Ghosh Samarendranath, Chatterjee Uttara, Bhattacharjee Pritha, Ghosh Anirban, Dichotomy in Growth and Invasion from Low- to High-Grade Glioma Cellular Variants, Cellular and Molecular Neurobiology, 42, 7, 2022. Crossref

  117. Welch E. Celeste, Yu Harry, Barabino Gilda, Tapinos Nikos, Tripathi Anubhav, Electric-field facilitated rapid and efficient dissociation of tissues Into viable single cells, Scientific Reports, 12, 1, 2022. Crossref

  118. Morales Daniel E., Mousa Shaker, Intranasal delivery in glioblastoma treatment: prospective molecular treatment modalities, Heliyon, 8, 5, 2022. Crossref

  119. Boyle Yasmin, Johns Terrance G., Fletcher Emily V., Potassium Ion Channels in Malignant Central Nervous System Cancers, Cancers, 14, 19, 2022. Crossref

  120. Batara Don Carlo Ramos, Zhou Shuchang, Choi Moon-Chang, Kim Sung-Hak, Glioblastoma organoid technology: an emerging preclinical models for drug discovery, Organoid, 2, 2022. Crossref

  121. Casado-Pelaez Marta, Bueno-Costa Alberto, Esteller Manel, Single cell cancer epigenetics, Trends in Cancer, 8, 10, 2022. Crossref

  122. Guo Tangjun, Bao Aijun, Xie Yandong, Qiu Jianting, Piao Haozhe, Single-Cell Sequencing Analysis Identified ASTN2 as a Migration Biomarker in Adult Glioblastoma, Brain Sciences, 12, 11, 2022. Crossref

  123. Alhaddad Lina, Osipov Andreyan N., Leonov Sergey, The Molecular and Cellular Strategies of Glioblastoma and Non-Small-Cell Lung Cancer Cells Conferring Radioresistance, International Journal of Molecular Sciences, 23, 21, 2022. Crossref

Begell Digital Portal Begell Digital Library eBooks Journals References & Proceedings Research Collections Prices and Subscription Policies Begell House Contact Us Language English 中文 Русский Português German French Spain